Tobramycin (Claris Lifesciences Inc.)


Welcome to the PulseAid listing for the Tobramycin drug offered from Claris Lifesciences Inc.. This Aminoglycoside Antibacterial [EPC],Aminoglycosides [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Claris Lifesciences Inc.
NON-PROPRIETARY NAME: Tobramycin
SUBSTANCE NAME: TOBRAMYCIN SULFATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Aminoglycoside Antibacterial [EPC],Aminoglycosides [Chemical/Ingredient]
ROUTE: INTRAMUSCULAR; INTRAVENOUS
DOSAGE FORM: INJECTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2016-07-15
END MARKETING DATE: 0000-00-00


Tobramycin HUMAN PRESCRIPTION DRUG Details:

Item DescriptionTobramycin from Claris Lifesciences Inc.
LABELER NAME: Claris Lifesciences Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 40(mg/mL)
START MARKETING DATE: 2016-07-15
END MARKETING DATE: 0000-00-00
PRODUCT ID: 36000-242_6524618f-c24e-4827-a07c-86e5bdc25078
PRODUCT NDC: 36000-242
APPLICATION NUMBER: ANDA206965

Other TOBRAMYCIN SULFATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Akorn, Inc.Tobramycin
Claris Lifesciences Inc.Tobramycin
Fresenius Kabi USA, LLCTobramycin
Hospira, Inc.Tobramycin
Mylan Institutional LLCTobramycin
Pfizer Laboratories Div Pfizer IncTobramycin Sulfate
Teva Parenteral Medicines, Inc.Tobramycin
X-GEN Pharmaceuticals, Inc.Tobramycin
Xellia Pharmaceuticals ApSTobramycin